Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer’s disease Ibero-American cohort [PDF]
INTRODUCTION: Some familial Alzheimer's disease (AD) cases are caused by rare and highly-penetrant mutations in APP, PSEN1, and PSEN2. Mutations in GRN and MAPT, two genes associated with frontotemporal dementia (FTD), have been found in clinically ...
Benitez, Bruno A +8 more
core +2 more sources
Glycoprotein 88 (GP88) is a secreted biomarker that is overexpressed in various cancers, neurological diseases such as Alzheimer's and Dementia, and inflammatory disorders. A disposable, rapid testing device for GP88 detection provides immediate marker‐level results, helping doctors monitor disease progression and therapy effectiveness. When optimized,
Elham Rezaee +2 more
wiley +1 more source
Antibody Characterization Report for Progranulin
Head-to-head comparison of available commercial antibodies against Progranulin by immunoblot (Western blot), immunoprecipitation and immunofluorescence. The following study was funded in part by Genome Québec's Genomics Integration Program, awarded to the research laboratory of Peter S. McPherson. This work is supported by the ALS-Reproducible Antibody
Alshafie, Walaa +4 more
openaire +1 more source
Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy.
Mislocalization, aberrant processing and aggregation of TAR DNA-binding protein 43 (TDP-43) is found in the neurons affected by two related diseases, amyotrophic lateral sclerosis (ALS) and frontotemporal lobe dementia (FTLD).
Angela S Laird +6 more
doaj +1 more source
Primary Phagocytosis of Neurons by Inflamed Microglia: Potential Roles in Neurodegeneration [PDF]
Microglial phagocytosis of dead or dying neurons can be beneficial by preventing secondary necrosis and release of pro-inflammatory intracellular components.
Jonas J. Neher +2 more
core +2 more sources
Electrochemical Immunosensor Glycoprotein 88 (GP88) is a secreted biomarker that is overexpressed in various cancers, as well as in neurological and inflammatory diseases. In the Research Article (DOI: 10.1002/adsr.202500122), Anna Ignaszak and co‐workers introduce the first disposable electrochemical immunosensor built on a screen‐printed electrode ...
Elham Rezaee +2 more
wiley +1 more source
Serum progranulin levels are associated with frailty in middle-aged individuals.
Background and objectiveA recent study identified progranulin as a candidate biomarker for frailty, based on gene expression databases. In the present study, we investigated associations between serum progranulin levels and frailty in a population-based ...
Andrew D Nguyen +5 more
doaj +1 more source
Alzheimer's disease polygenic risk in early‐ and late‐onset Alzheimer's disease
Abstract INTRODUCTION The genetic basis of sporadic early‐onset Alzheimer's disease (EOAD) remains largely unknown, prompting evaluation of late‐onset Alzheimer's disease (LOAD) polygenic risk in EOAD. METHODS A LOAD polygenic score (PGS) was calculated in the Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) and Alzheimer's Disease ...
Julian V. Pentchev +56 more
wiley +1 more source
Correlating familial Alzheimer’s disease gene mutations with clinical phenotype [PDF]
Alzheimer’s disease (AD) causes devastating cognitive impairment and an intense research effort is currently devoted to developing improved treatments for it.
Rossor, M.N., Ryan, N.S.
core +1 more source
Effects of sex hormone treatment on the metabolic syndrome in transgender individuals : focus on metabolic cytokines [PDF]
Context: Hormonal treatment in transgender persons affects many components of the metabolic syndrome (MS). Objective: To determine the role of direct hormonal effects, changes in metabolic cytokines, and body composition on metabolic outcomes.
Auer, Matthias K +6 more
core +2 more sources

